Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Liabilities and Shareholders Equity (2016 - 2025)

CV Sciences (CVSI) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 12.17% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.7 million through Dec 2025, down 11.89% year-over-year, with the annual reading at $7.0 million for FY2025, 12.17% down from the prior year.
  • Liabilities and Shareholders Equity hit $7.0 million in Q4 2025 for CV Sciences, roughly flat from $7.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $30.7 million in Q1 2021 to a low of $7.0 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $13.3 million across 5 years, with a median of $9.8 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: tumbled 43.34% in 2022 and later dropped 8.33% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $18.1 million in 2021, then fell by 29.5% to $12.7 million in 2022, then decreased by 27.76% to $9.2 million in 2023, then decreased by 13.84% to $7.9 million in 2024, then fell by 12.17% to $7.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CVSI at $7.0 million in Q4 2025, $7.0 million in Q3 2025, and $8.0 million in Q2 2025.